MAM
Panasonic India names Fumiyasu Fujimori as divisional director, consumer sales
Mumbai: Tech major Panasonic India on Monday announced the appointment of Fumiyasu Fujimori as divisional director, consumer sales division. He will be based out of Panasonic India headquarters in Gurgaon.
Fujimori joined the company in 1995 in Osaka, Japan. In his career spanning 26 years, he has worked in various international markets such as China, Singapore and Thailand overseeing strategy planning, business development, and marketing communications across business divisions of Panasonic.
In his previous role, Fujimori was based in Japan, where he was leading the global marketing efforts for Panasonic’s Imaging Business Unit (Lumix, digital cameras).
“It is an important time for Panasonic India as we strengthen our presence across consumer appliances and smart living solutions in India,” said Panasonic India CEO Manish Sharma. “Fujimori’s rich experience of working with Panasonic across many markets will certainly contribute to the growth of our business here in India.”
“My first stint here was in 2009 as part of the audio team, where I got an opportunity to gain market experience. I believe, this is a high-potential market that offers significant growth opportunities and as I resume my new role here I am looking forward to leveraging this potential through strategic interventions and providing Indian consumers with a value proposition,” stated Fumiyasu Fujimori on his new role.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
